TNF and type 2 diabetes mellitus: Chronic inflammation also promotes IR by increasing tumor necrosis factor-α (TNF-α), a proinflammatory cytokine elevated in T2DM, which inhibits glucose transport by reducing glucose transporter type 4 (GLUT4) [3,4].